Absci CorporationABSINASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank60
3Y CAGR-51.6%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
-51.6%/yr
Annual compound
Percentile
P60
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202432.85%
2023-18.40%
202232.12%
2021289.47%
2020165.55%
20190.00%